20th Clinical Trials Innovation Programme: October 26 – 27, 2022

Join World BI and Redenlab for the 20th Clinical Trials Innovation Programme, to learn from experts in the drug development industry.

Hear from CEO Dr Adam Vogel and other leading industry experts exploring the future of clinical trials, patient centricity, and drug development digitalisation post COVID. 26 – 27 October 2022, Boston.

To find out more and register, click here.

Related Post

The characteristics and reproducibility of motor speech functional neuroimaging in healthy controls

  • Posted on 19 November, 2024
    Functional magnetic resonance imaging (fMRI) offers valuable insights into how the brain controls motor speech functions. However, there are still...
    Read more

    International Congress for Ataxia Research 2024

    • Posted on 12 November, 2024
      Redenlab is excited to announce that Prof. Adam Vogel will be speaking at the upcoming International Congress for Ataxia Research...
      Read more

      Longitudinal objective assessment of speech in Multiple Sclerosis

      • Posted on 31 October, 2024
        Remote speech tests can complement in-clinic exams to help guide treatment for Multiple Sclerosis (MS). Previous studies suggested that speech...
        Read more